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Abstract. The behavioral  effects o f  single doses o f  
phencyclidine (PCP) were examined in drug-naive adult  
male Hol tzman  rats trained to press a bar on a fixed 
ratio (4) schedule (FR4), i.e., a reward of  sugar- 
sweetened milk was earned on every four th  bar press. 
Groups  of  rats (four to eight rats per group) received 
specific doses of  PCP which were held constant  for each 
group th roughout  the study. Dose-response curves for 
PCP given in doses of  1.0, 1.8, 2.4, and 3.2 mg/kg IP 
were first determined and then redetermined at weekly 
intervals. A drug-free interval of  7 -  8 days was main- 
tained between injections given weekly over a period o f  
4 weeks. The final dose of  PCP was administered after a 
4-week drug-free period. Evidence was obtained for 
first dose behavioral  tolerance as shown by the signif- 
icantly shortened durat ion o f  suppression o f  bar  press- 
ing on subsequent injections. Al though  subsequent 
weekly effects of  equal doses of  PCP showed no 
significant differences, they all differed significantly 
f rom the first injection. The reduced response to PCP 
was shown to be due to learned behavioral  tolerance as 
demonst ra ted  when PCP (3.2 mg/kg  IP) was given to 
drug-naive animals in their home cages and 1 week later 
given the second dose in the operant  behavioral si- 
tuation. Under  these circumstances, the second dose o f  
PCP showed a similarly protracted depression of  FR4 
responding as other animals given the drug for the first 
time in the operant  situation. Subsequent  weekly 
injections in the operant  situation produced similar 
behavioral  tolerance. 
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The unique central nervous system activity o f  phencyc- 
lidine (PCP) is generally acknowledged. It encompasses 
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characteristics o f  a local and general anesthetic with 
psychomotor  stimulation, sedation, and schizophreno- 
mimetic properties (Domino,  1964, 1978; Luby et al., 
1962). Currently, PCP is a major  drug of  abuse. Serious 
toxicity has been reported f rom the use of  PCP and 
especially the preparat ions that  are available on the 
street (Burns and Lerner, 1976; Burns et al., 1975; 
Eas tman and Cohen,  1975). 
In view of  the influence o f  behavioral  factors on the 
effects of  psychoactive drugs in specific circumstances 
(LeBlanc et al., 1973; McKearney  and Barrett, 1978; 
Dews, 1962, 1978), the study was initiated to compare  
the possibility o f  behavioral-environmental  factors 
influencing the effects of  PCP. The objectives were to 
investigate the behavioral  effects o f  PCP coupled with 
an examinat ion o f  observed first dose behavioral  
tolerance. 
Materials and Methods 
Subjects. Adult male Holtzman rats at least 90 days old were housed 
individually in a constant temperature and humidity facility and, 
maintained at approximately 70 % of their expected free-feeding 
weight. 
Procedures. Food-rewarded bar pressing was established by training 
rats to press a bar for 1 h daily to receive 0.01 ml of a sugar water- 
evaporated milk solution as positive reinforcement. The milk was 
prepared by combining 400 rnl evaporated milk with 400 ml tap 
water and 60 g granulated sugar. The daily bar pressing schedule was 
a fixed ratio (4) (FR4), i.e., every fourth bar press earned a reward. 
Experiments were conducted in a darkened isolated room using 
Lehigh Valley Electronics rodent operant test cages (model 143 - 21). 
Cumulative recorders automatically recorded bar presses, reinforce- 
ments, and any disruption of normal bar pressing during daily 
sessions. After achieving stable FR 4 behavior, each rat was then 
assigned a daily 60-min bar pressing schedule for at least 5 days prior 
to any injections. Procedures for training and experiments were 
similar to those described by Kovacic et al. (1978) and Ruffing et al. 
(1979). Animals used in this study had no past drug history. To 
examine the effects of PCP, each assigned group received one specific 
dose for the entire study with each rat serving as its own control. A 
drug-free interval of 7 -  8 days was observed between injections, with 
the exception of the last injections, which required a drug-free interval 
of 4 weeks. Log spaced doses of PCP (1.0, 1.8, 2.4, and 3.2 mg/kg) 
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were administered IP to disrupt food-rewarded FR 4 bar pressing in a 
dose-related fashion. Pretreatments with 0.9 ~ NaC1 were not used 
for control reactions, since it had been demonstrated in previous 
studies (using identical as well as similar saline pretreatment 
schedules) that such vehicle controls revealed no disruptive effects on 
bar pressing responses or any alteration in drug effect reactions 
(Kovacic and Domino, 1976; Kovacic et al., 1978). 
In the control procedures rats were placed in an operant chamber 
for 1 5 - 2 0  min of  bar pressing, injected IP with PCP, and returned 
immediately to the operant chamber until the rat recovered and 
pressed the bar steadily at a rate of 90 ~ of  control for a 60-min 
period. Groups of rats, receiving specific PCP doses, were given the 
same dose throughout the study. After determining the duration of 
the initial response for PCP doses 1.0, 1.8, 2.4, and 3.2 mg/kg IP), 
each of these groups (groups, A - D ,  respectively) were retested to 
resolve the question of possible long-term PCP effects and to 
substantiate reproducible behavioral drug results. The control retest- 
ing procedure was repeated for 3 uninterrupted weeks. Drug-free 
intervals of 7 - 8  days were observed between injections one to 
three and a 4-week drug-free interval for the final injection. At 
least 2 consecutive days of 60-rain bar pressing sessions were required 
for all groups prior to additional PCP injections. At this time, typical 
drug-free behavioral bar pressing activity at control rates was 
recorded. Behavioral responses were noted for the duration of the 
drug effects. 
A second 3.2 mg/kg PCP control groups was instituted to clarify 
the influence of environmental circumstances modifying the be- 
havioral effects of  PCP. The second group (group E) was exposed to 
an identical control schedule with the exception t h a t  the initial 
injection was administered in the home cage following the bar 
pressing session (rather than the usual procedure of injecting in the 
operant chamber during the bar pressing session). Behavioral 
responses were noted for duration of the drug effects. 
Three additional groups of eight animals each were used to 
compare the effects of PCP (1.0 and 1.8 mg/kg) to those of N,N- 
dimethyltryptamine (DMT) (3.2 and 10.0mg/kg) and LSD 
(0.1 mg/kg). Identical procedures were followed with all groups, with 
the exception that the total number of  injections per group was 
two. 
Data Analysis, The duration of PCP effects was measured by the 
horizontal line generated from the cumulative recorder during any 
disruption of  bar pressing behavior. Paired-comparison t-tests were 
used to statistically analyze the data and were calculated according to 
Snedecor (1956) using the value of P < 0.05 as significant. 
Drugs. Phencyclidine HC1 (Sernylan, Bio-Ceutic Laboratories, St. 
Joseph, MO) was diluted with 0 .9~  NaC1 to the appropriate 
concentrations. DMT (Sigma Chemical, St. Louis, MO) was pre- 
pared by dissolving the free base in 1 N HCI, adding 0.9 ~ NaCI, and 
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Fig. l.  Dose effect of PCP doses (1.0, 1.8, 2.4, and 3.2 mg/kg) in the suppression of F R ,  behavior in the rat. In groups A - D ,  PCP control 
injections one to three were administered after 7 - 8 day drug-free intervals between injections, while a 4 week drug-free interval was observed for 
the final PCP control. Each group of  five to nine rats and assigned PCP dose was held constant for the entire study with each rat serving as its own 
control. All injections were administered IP. Group E (five rats) received the first PCP injection while in the home cage with succeeding injections 
administered in the operant chamber situation. When groups D and E were initially injected in the operant chamber, significant reductions of the 
initial drug response occurred in the proceeding injections (injection 2 in group D and injection 3 in group El). In group E, seven day drug-free 
intervals were observed between injections one to four with each rat serving as its own control. In this and the subsequent figure paired com- 
parison Student's t-tests were done in which the following symbols apply: * P < 0.05; ** P < 0.01 ; *** P > 0.001 
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refer to LSD-25 substance obtained from the National Institute on 
Drug Abuse. All doses for PCP, DMT, and LSD refer to free base. 
R e s u l t s  
Doses of 1.0, 1.8, 2.4, and 3.2 mg/kg PCP disrupted bar 
pressing behavior in a dose-related fashion and pro- 
duced gross behavioral reactions within approximately 
5 min following IP injections. Gross behavioral re- 
actions included marked ataxia, motor  hyperactivity, 
repetitious head and body movements,  cage circling, 
crawling in a flattened position, walking backwards, 
occasional Straub tail, excessive floor sniffing, mus- 
cular twitching, salivation, and lacrimation. These 
observations are consistent with reactions reported by 
Domino (1964), Chait and Balster (1978), and Chen et 
al. (1959, 1965). After cessation of bar pressing, the rats 
would begin and continue bar pressing for 60 min at 
preinjection rates. 
Figure 1 illustrates (groups A - D )  the longer 
duration of the first dose behavioral effects with 
reproducible stable responses in succeeding weekly 
doses. The reduction of  drug responses noted between 
the first and second injections (Fig. 1) was shown to be 
due to learned behavioral tolerance. Figure 1 shows 
that when the first dose environmental situation was 
altered in group E (by administering the first dose of  
PCP to rats in their home cages and succeeding weekly 
doses in the operant chamber), the longer duration of 
drug-induced response disruptions occurred with the 
second dose and the markedly reduced drug response 
disruptions were maintained following the third dose, 
etc. 
The prolonged suppression of FR 4 behavior was 
exclusive for the first dose and no changes in drug 
response were noted following a 4 week drug-free 
interval (Fig. 1). 
The observed first dose tolerance is unique to PCP 
when compared with other hallucinogenic drugs (on 
identical schedules) in drug-naive rats given D M T  (3.2 
and 10.0 mg/kg IP) and LSD (0.1 mg/kg IP). Figure 2 
shows two consecutive injections of  each drug while 
observing a seven day drug-free interval between the 
first and second injections. 
Because of deteriorating health and/or unsatisfac- 
tory drug-free bar pressing records, several rats had to 
be excluded from the study resulting in a change in the 
number (N) of  rats per group. The cause of this 
deterioration was undetermined, but seemed directly 
related to toxic PCP effects. 
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Fig. 2. Comparison ofFR 4 behavioral drug effects of PCP (1.0 and 1.8 mg/kg), DMT (3.2 and 10.0 mg/kg), and LSD (0.1 mg/kg). Injections were 
administered observing seven day drug-free intervals between injections. All animals were drug-naive before the initial dose of each drug shown. 
All injections were administered IP, with eight rats in the PCP 1.0 mg/kg group; six rats in the PCP 1.8 mg/kg group ; and eight rats representing 
the DMT and LSD groups. First dose behavioral tolerance is shown to be exclusive for the PCP groups in the F R  4 behavioral situation 
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Discussion 
In  spite of the evidence that  behavioral  tolerance has 
been observed to a large n u m b e r  of psychoactive drugs 
(Krasnegor ,  1978), to our  knowledge, it has no t  been 
reported with PCP, and  especially so dramatical ly with 
the first dose as reported here. 
Consis tent  gross behavioral  reactions to PCP were 
seen th roughou t  the study, a l though all groups dis- 
played a large variabil i ty in the dura t ion  of drug effect 
times and  a few select rats showed greater sensitivity 
and /or  longer dura t ions  of F R  4 suppression. As the 
study progressed, rats became increasingly difficult to 
handle  and  unusua l ly  aggressive. After  a per iod of 3 - 4 
months  following the concluding PCP injections, an 
as tounding  45% mortal i ty  rate was noted. In  our  
experience with other drugs, such a deter iorat ion in 
performance  is highly unusual ,  suggesting chronic 
toxicity to PCP. Nonspecif ic  toxicity, as well as long- 
term behavioral  effects f rom PCP have been reported 
(Burns et al., 1975; Linden  et al., 1975; Tong  et al., 
1975; F a u m a n  et al., 1975; James and  Schnoll, 1976). 
Fur ther  research on chronic PCP toxicity is clearly 
indicated. 
The first dose PCP induced behavioral  tolerance 
further emphasizes the p ro found  influence of be- 
havioral  factors on the effects of psychoactive drugs. 
The use of animals  t ra ined on various operant  
schedules to examine the effects of  various drugs should 
be carefully evaluated in view of the striking evidence of 
behavioral  tolerance to a single dose of PCP. 
Whether  single dose behavioral  PCP tolerance 
applies to other behavioral  paradigms in the rat  and  
other species, inc luding man,  remains for future re- 
search to answer. 
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